Originally presented August 26, 2020 as part of the UNC Lineberger Cancer Network Research to Practice Lecture Series. Course expires November 10 2021.

Presenter

Shetal A. Patel, MD, PhD
Assistant Professor
Clinical Research
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Lung Cancer Management in North Carolina:
Updates for 2020

Shetal Patel, MD, PhD, from the UNC Lineberger Thoracic Oncology group will describe relevant updates in systemic therapy for lung cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.

Learning Objectives

• Recognize biomarkers for targeted therapy selection for patients with non-small cell lung cancer
• Compare immune checkpoint inhibitor treatment options for metastatic non-small cell lung cancer
• Describe the role of immune checkpoint inhibitors in small cell lung cancer

Credits Offered

1.0 ANCC (CNE) hours of study.

1 ASRT Category A CE Credit

1.0 AMA PRA Category 1 Credit™

1.0 ACPE CE Credit

General Participation

Requirements

To receive credit for this course, you must:

• Watch a lecture video recording.
• Complete the lecture post test and obtain a passing score of 80% or higher.
• Complete the course evaluation.
• Select credit type.

Estimated course completion time: 1 hour

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. William A Wood, MD, MPH, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

Shetal A. Patel, MD, PhD, receives research support from AstraZeneca and has no other relevant financial relationships with commercial interests as defined by the ACCME.

Accreditation

The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Approved by the UNC Eshelman School of Pharmacy for ACPE.

Approved by the American Society of Radiologic Technologists (ASRT).

The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.